Stroke prevention: Narrowing the evidence-practice gap

Neurology

Volumn 54, Issue 10, 2000, Pages 1899-1906

  Holloway, Robert G ^a   Benesch, Curtis ^a   Rush, Steven R ^b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b AMERICAN ACADEMY OF NEUROLOGY   (United States)

Author keywords

Health services; Prevention; Risk factors; Stroke

Indexed keywords

EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STROKE;

EID: 0034705219     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.54.10.1899     Document Type: Review

References (56)

1. Gorelick PB, Sacco RL, Smith DB, et al. Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA 1999;281:1112-1120.
2. Hankey GJ, Warlow CP. Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations. Lancet 1999;354:1457-1463.
3. Collins R, Peto R, MacMahon S. Blood pressure, stroke and coronary heart disease. II: Effects of short-term reductions in blood pressure and overview of the unconfounded randomized drug trials in an epidemiologic context. Lancet 1990;335:827-838.
4. Hess DC, Demchuk AM, Brass LM, Yatsu FM. HMG-CoA reductase inhibitors (statins): a promising approach to stroke prevention. Neurology 2000;54:790-796.
5. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Practice Parameter: stroke prevention in patients with nonvalvular atrial fibrillation. Neurology 1998;51:671-673.
6. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273:1421-1428.
7. Loh E, Sutton MS, Wun CC, et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med 1997;336:251-257.
8. Ansell JE, Buttaro ML, Boltis O, Knowlton CH, Anticoagulation Guidelines Task Force. Consensus guidelines for coordinated outpatient oral anticoagulation therapy management. Ann Pharmacother 1997;31:604-615.
9. Fiore MC, Bailey WC, Cohen SJ, et al. Smoking cessation. Clinical practice guideline no. 18. AHCPR publication no. 96-0692. Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1996.
10. American Diabetes Association. Clinical practice recommendations 1998. Diabetes Care 1998;21(suppl 1):S1-S89.
11. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308:81-106.
12. Mass WK, Easton JD, Adams HP, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989; 321:501-507.
13. CAPRIE Steering Committee. A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-1338.
14. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in secondary prevention of stroke. J Neurol Sci 1996;146:1-13.
15. The INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators, Gueyffier F, Boissel J, et al. Effect of antihypertensive treatment in patients having already suffered from stroke - gathering the evidence. Stroke 1997;28:2557-2562.
16. Cina CS, Clase CM, Haynes RB. Carotid endarterectomy in patients with symptomatic carotid stenosis (Cochrane Review). The Cochrane Library, issue 3, 1999. Oxford: Update Software, 1-13.
17. Stroke Unit Trialists' Collaboration. Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke. BMJ 1997;314:1151-1159.
18. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993;342: 1255-1262.
19. National Cholesterol Education Program Expert Panel. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 1993;269:3015-3023.
20. Kalra L, Perez I, Melbourn A. Stroke risk management: changes in mainstream practice. Stroke 1998;29:53-57.
21. Klungel OH, Stricker BHC, Paes AHP, et al. Excess stroke among hypertensive men and women attributable to under-treatment of hypertension. Stroke 1999;30:1312-1318.
22. Burt VL, Whelton P, Pocella EJ, et al. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:305-313.
23. Sueta CA, Chowdhury M, Smith SC Jr, et al. Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease. Am J Cardiol 1999;83:1303-1307.
24. Brass LM, Krumholz HM, Scinto JM, Radford MJ. Warfarin use among patients with atrial fibrillation. Stroke 1997;28: 2382-2389.
25. Gordon DL, Cobb AB, McIlwain JS, et al. Cooperative stroke management project by a peer-review organization. J Stroke Cerebrovasc Dis 1996;6:45-53.
26. Joseph LN, Babikian VL, Allen NC, Winter MR. Risk factor modification in stroke prevention: the experience of a stroke clinic. Stroke 1999;30:16-20.
27. Kernan WN, Viscoli CM, Brass LM, Makuch RW, Sarrel PM, Horowitz RI. Blood pressure exceeding national guidelines among women after first stroke. Stroke 2000;31:415-419.
28. Goldstein LB, Hey LA, Laney R. North Carolina Stroke Prevention and Treatment Facilities Survey. Stroke 2000;31: 66-70.
29. Rogers EM. Attributes of innovations and their rate of adoption. In: Rogers EM, ed. Diffusion of innovations. 4th ed. New York, NY: The Free Press, 1995:204-251.
30. Samsa GP, Cohen SJ, Goldstein LB, et al. Knowledge of risk among patients at increased risk for stroke. Stroke 1997;28: 916-921.
31. Accreditation Council for Graduate Medical Education. Graduate medical education directory 1998-1999. Chicago, IL: American Medical Association, 1998.
32. Grimes DA. Technology follies: the uncritical acceptance of medical innovation. JAMA 1993;269:3030-3032.
33. Margolis CZ, Cretin S, eds. Implementing clinical practice guidelines. Chicago, IL: American Heart Association, 1999.
34. Haines A, Donald A, eds. Getting research findings into practice. London: BMJ Publishing Group, 1998.
35. Davis DA, Thomson MA, Oxman AD, Haynes B. Changing physician performance: a systematic review of the effect of continuing medical education strategies. JAMA 1995;274: 700-705.
36. Cohen SJ, Halvorson HW, Gosselink CA. Changing physician behavior to improve disease prevention. Prev Med 1994;23: 284-291.
37. Lomas J, Anderson GM, Domnick-Peirre K, Vayda E, Enkin MW, Hannah WJ. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. N Engl J Med 1989;321:1306-1311.
38. Thomson MA, Oxman AD, Haynes RB, Davis DA, Freemantle N, Harvey EL. Local opinion leaders to improve health professional practice and health care outcomes (Cochrane Review). The Cochrane Library 1997. 1-10.
39. Soumerai S.B., Avorn J. Principles of educational outreach ('Academic Detailing') to improve clinical decision making. JAMA 1990;263:549-556.
40. Balas EA, Austin SM, Mitchell JA, Ewigman BG, Bopp KD, Brown JD. The clinical value of computerized information services. A review of 98 randomized clinical trials. Archives of Family Medicine 2000;5:271-278.
41. Shea S, DuMouchel W, Bahamonde L. A meta-analysis of 16 randomized controlled trials to evaluate computer-based clinical reminder systems for preventive care in the ambulatory setting. J Am Med Inform Assoc 1996;3:399-409.
42. Grilli R, Freemantle N, Minozzi S, Domenighetti G, Finer D. Mass media interventions: effects on health services utilisation (Cochrane Review). The Cochrane Library 1999. Oxford: Update Software, 1-18.
43. Thomson O'Brien MA, Oxman AD, Davis DA, Haynes RB, Freemantle N, Harvey EL. Audit and feedback versus alternative strategies: effects on professional practice and health care outcomes (Cochrane Review). The Cochrane Library, issue 4, 1999. Oxford: Update Software, 1-10.
44. Stross JK. Guidelines have their limits. Ann Intern Med 1999; 131:304-306.
45. Shaneyfelt TM, Mayo-Smith JF, Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA 1999;281:1900-1905.
46. McGlynn EA, Asch SM. Developing a clinical performance measure. Am J Prev Med 1998;14:14-21.
47. Hankey GJ. Stroke: how large a public health problem, and how can the neurologist help? Arch Neurol 1999;56:748-754.
48. US Preventive Services Task Force. Patient education/counseling strategies. In: Guide to clinical preventive services. 2nd ed. Washington, DC: US Department of Health and Human Services, 1996.
49. Silagy C, Ketteridge S. Physician advice for smoking cessation (Cochrane Review). The Cochrane Library, issue 4, 1999. Oxford: Update Software, 1-14.
50. Mullen PD, Mains DA, Velez R. A meta analysis of controlled trials of cardiac education. Patient Education Counseling 1992;19:143-162.
51. Rice VH, Stead LF. Nursing interventions for smoking cessation (Cochrane Review). The Cochrane Library, issue 4, 1999. Oxford: Update Software, 1-14.
52. Campbell NC, Ritchie LD, Thain J, Deans HG, Rawles JM, Squair JL. Secondary prevention in coronary heart disease: a randomised trial of nurse led clinics in primary care. Heart 1998;80:447-452.
53. Haynes RB, Montague P, Oliver T, McKibbon KA, Brouwers MC, Kanani R. Interventions for helping patients follow prescriptions for medications (Cochrane Review). The Cochrane Library, issue 4, 1999. Oxford: Update Software, 1-25.
54. Simons LA. Apparent discontinuation rates in patients prescribed lipid-lowering drugs. Med J Aust 1996;164:208-211.
55. Allen H. Promoting compliance with antihypertensive medication. Br J Nurs 1998;7:1252-1258.
56. Morris LS, Schultz RM. Patient compliance - a review. J Clin Pharm Ther 1992;17:283-295.